| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e11815dee6df9a74cfdb05a0a282703b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fa83752c38c4a8a4a6939b187bf6e71 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate |
2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e520bb5b85eabedd42bef8a56ff7535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e413b366eb77e1b48308ab7aad6bf999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c77e69159a29fd83896191d9e769af41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9e2a83ea502ad4ecf35778aea377e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e03bd75a271214232fbf91ebc3390efd |
| publicationDate |
2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019133690-A1 |
| titleOfInvention |
Transdermal drug delivery system and method for using same |
| abstract |
A method for administering a drug to a diseased portion is achieved in a short time and predominantly improves the administration amount (transdermal permeation amount) of the drug in treatment of eyelid disease or palpebral conjunctiva disease. The method for administering a drug for treatment of eyelid disease or palpebral conjunctiva disease includes a step of microneedle perforation by using a microneedle device into a tissue of the eyelid including a meibomian gland of a patient suffering from or suspected of having the disease, in which drug-containing coating is applied to at least a part of a surface of the microneedle, and the drug is a water-soluble drug. |
| priorityDate |
2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |